CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity

NCT01066728 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Apnea of Prematurity

Interventions

OTHER: CO2 inhalation
DRUG: Theophylline

Sponsor

University of Manitoba

Collaborators

[object Object]
[object Object]